Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
| Co-prescribed Drug | Interaction Pathway | Effect on Co-Drug | Severity | Clinical Action | |---|---|---|---|---| | Warfarin | Hepatic CYP2C9 induction (GCGR) | Reduced anticoagulant effect
Instead, CMS is extending the duration of a separate short-term program, called the Medicare GLP-1 Bridge, which was originally scheduled to run from July-December 2026 but will now run through the end of 2027
Damman K, Valente MA, Voors AA, O'Connor CM, van Veldhuisen DJ, Hillege HL
Valproic acid, another mood stabilizer, causes weight gain in up to 30% of patients
Md 75, 15231538
Sachan et al
US$ 20.33
US$ 27.28
US$ 27.19
US$ 25.15
US$ 28.06
